CN109072173A - 克里斯坦森氏菌(Christensenella intestinihominis)及其应用 - Google Patents

克里斯坦森氏菌(Christensenella intestinihominis)及其应用 Download PDF

Info

Publication number
CN109072173A
CN109072173A CN201680083545.0A CN201680083545A CN109072173A CN 109072173 A CN109072173 A CN 109072173A CN 201680083545 A CN201680083545 A CN 201680083545A CN 109072173 A CN109072173 A CN 109072173A
Authority
CN
China
Prior art keywords
salmonella
composition
clayton
christensen
clayton christensen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680083545.0A
Other languages
English (en)
Inventor
邹远强
薛文斌
吕梅
肖亮
李晓平
余靖宏
刘传
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BGI Shenzhen Co Ltd
Original Assignee
BGI Shenzhen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BGI Shenzhen Co Ltd filed Critical BGI Shenzhen Co Ltd
Publication of CN109072173A publication Critical patent/CN109072173A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

提供了克里斯坦森氏菌(Christensenella intestinihominis)及其应用，具体是克里斯坦森氏菌(Christensenella intestinihominis)在治疗和预防肥胖及其相关疾病中的用途，还提供了一种用于治疗和预防肥胖及其相关疾病的组合物，包括药品、饮料、食品，或动物饲料组合物等，以及降低体重、和/或血脂的方法。

Description

PCT国内申请，说明书已公开。

Claims (10)

  1. PCT国内申请，权利要求书已公开。
CN201680083545.0A 2016-09-06 2016-09-06 克里斯坦森氏菌(Christensenella intestinihominis)及其应用 Pending CN109072173A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2016/098247 WO2018045493A1 (zh) 2016-09-06 2016-09-06 克里斯坦森氏菌(Christensenella intestinihominis)及其应用

Publications (1)

Publication Number Publication Date
CN109072173A true CN109072173A (zh) 2018-12-21

Family

ID=61561231

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680083545.0A Pending CN109072173A (zh) 2016-09-06 2016-09-06 克里斯坦森氏菌(Christensenella intestinihominis)及其应用

Country Status (5)

Country Link
US (1) US10806759B2 (zh)
EP (1) EP3511407B1 (zh)
JP (1) JP6782302B2 (zh)
CN (1) CN109072173A (zh)
WO (1) WO2018045493A1 (zh)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113750113A (zh) * 2020-06-01 2021-12-07 山东新时代药业有限公司 一种益生菌和益生元的组合物及其应用
CN114259507A (zh) * 2021-12-27 2022-04-01 暨南大学 一种小克里斯滕森氏菌在制备治疗和/或预防高尿酸相关疾病的药物中的应用
WO2022213507A1 (zh) * 2021-04-06 2022-10-13 慕恩（广州）生物科技有限公司 一种细菌菌株及组合物、联用药物和用途
CN115369050A (zh) * 2021-05-17 2022-11-22 中国科学院微生物研究所 一株小克里斯滕森氏菌sj-2及其应用
CN116919994A (zh) * 2023-09-15 2023-10-24 中国农业大学 小克里斯滕森氏菌在制备治疗多囊卵巢综合征的产品中的应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101912774B1 (ko) 2016-11-21 2018-10-29 한국식품연구원 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
KR101797926B1 (ko) * 2016-11-21 2017-11-15 한국식품연구원 포름산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
EP3958882A1 (fr) * 2019-04-25 2022-03-02 YSOPIA Biosciences Bactérie de la famille des christensenellacées dans la prévention et/ou le traitement de l'hypertriglycéridémie
FR3095339A1 (fr) * 2019-04-25 2020-10-30 Lnc Therapeutics Bactérie de la famille des Christensenellacées dans la prévention et/ou le traitement de l’hypertriglycéridémie
CN114728026A (zh) 2019-08-28 2022-07-08 未知君有限责任公司 包含细菌物种的组合物及与其相关的方法
CN115998772A (zh) * 2021-04-06 2023-04-25 慕恩（广州）生物科技有限公司 一种细菌菌株及组合物和用途
CN113230387A (zh) * 2021-04-06 2021-08-10 慕恩（广州）生物科技有限公司 包含微生物和降糖降脂药物的联用药物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014082050A1 (en) * 2012-11-23 2014-05-30 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
WO2016086209A1 (en) * 2014-11-25 2016-06-02 Epiva Biosciences, Inc. Probiotic and prebiotic compositions, and methods of use thereof for treatment of gastrointestinal disorders
CN107708704A (zh) * 2015-04-23 2018-02-16 卡莱多生物科技有限公司 微生物组调节剂和其相关用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2389547B1 (es) * 2010-12-07 2013-08-08 Consejo Superior De Investigaciones Científicas (Csic) Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
US10206958B2 (en) * 2014-04-23 2019-02-19 Cornell University Modulation of fat storage in a subject by altering population levels of christensenellaceae in the GI tract

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014082050A1 (en) * 2012-11-23 2014-05-30 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
WO2016086209A1 (en) * 2014-11-25 2016-06-02 Epiva Biosciences, Inc. Probiotic and prebiotic compositions, and methods of use thereof for treatment of gastrointestinal disorders
CN107708704A (zh) * 2015-04-23 2018-02-16 卡莱多生物科技有限公司 微生物组调节剂和其相关用途

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIJAYA UPADHYAYA 等: "Impact of dietary resistant starch type 4 on human gut microbiota and immunometabolic functions", 《SCIENTIFIC REPORTS》 *
MASAMI MOROTOMI 等: "Description of Christensenella minuta gen. nov., sp. nov., isolated from human faeces, which forms a distinct branch in the order Clostridiales, and proposal of Christensenellaceae fam. nov.", 《INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY》 *
ZOU,Y. 等: "GenBank: KX078376.1，"Christensenella sp. AF73-05CM02 16S ribosomal RNA gene, partial sequence"", 《GENBANK》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113750113A (zh) * 2020-06-01 2021-12-07 山东新时代药业有限公司 一种益生菌和益生元的组合物及其应用
CN113750113B (zh) * 2020-06-01 2022-12-02 山东新时代药业有限公司 一种益生菌和益生元的组合物及其应用
WO2022213507A1 (zh) * 2021-04-06 2022-10-13 慕恩（广州）生物科技有限公司 一种细菌菌株及组合物、联用药物和用途
CN115369050A (zh) * 2021-05-17 2022-11-22 中国科学院微生物研究所 一株小克里斯滕森氏菌sj-2及其应用
CN114259507A (zh) * 2021-12-27 2022-04-01 暨南大学 一种小克里斯滕森氏菌在制备治疗和/或预防高尿酸相关疾病的药物中的应用
CN116919994A (zh) * 2023-09-15 2023-10-24 中国农业大学 小克里斯滕森氏菌在制备治疗多囊卵巢综合征的产品中的应用
CN116919994B (zh) * 2023-09-15 2023-12-08 中国农业大学 小克里斯滕森氏菌在制备治疗多囊卵巢综合征的药物中的应用

Also Published As

Publication number Publication date
US20190282633A1 (en) 2019-09-19
US10806759B2 (en) 2020-10-20
EP3511407A4 (en) 2020-04-08
JP6782302B2 (ja) 2020-11-11
EP3511407A1 (en) 2019-07-17
EP3511407B1 (en) 2023-05-17
JP2019517992A (ja) 2019-06-27
WO2018045493A1 (zh) 2018-03-15

Similar Documents

Publication Publication Date Title
CN109072173A (zh) 克里斯坦森氏菌(Christensenella intestinihominis)及其应用
US11484583B2 (en) Intestinal bacteria Butyribacter intestini and application thereof
CN111280252B (zh) 长双歧杆菌长亚种、含其的组合物及用途
CN109504615A (zh) 单形巨单胞菌（Megamonas funiformis）及其应用
CN110023486A (zh) 一种嗜酸乳杆菌及其培养方法和应用
WO2018112740A1 (zh) 一种加氏乳杆菌及其培养方法和应用
CN109219656A (zh) 长栖粪杆菌（Faecalibacterium longum）及其应用
US11191790B2 (en) Biologically pure Faecalibacterium butyricigenerans strain, composition including the same and method for treating ulcerative colitis
WO2019051789A1 (zh) 粪厌氧棒形菌(Anaerofustis stercorihominis)及其应用
CN110062806A (zh) 粪厌氧棒杆菌(Anaerostipes caccae)及其应用
CN110049772A (zh) 深圳柯林斯菌(Collinsella shenzhenensis)及其应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40000506

Country of ref document: HK